CONMED Current Ratio 2010-2023 | CNMD
CONMED current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| CONMED Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-12-31 |
$0.62B |
$0.31B |
1.98 |
| 2023-09-30 |
$0.63B |
$0.38B |
1.66 |
| 2023-06-30 |
$0.62B |
$0.35B |
1.74 |
| 2023-03-31 |
$0.61B |
$0.32B |
1.90 |
| 2022-12-31 |
$0.58B |
$0.30B |
1.96 |
| 2022-09-30 |
$0.57B |
$0.21B |
2.75 |
| 2022-06-30 |
$0.58B |
$0.20B |
2.87 |
| 2022-03-31 |
$0.49B |
$0.19B |
2.60 |
| 2021-12-31 |
$0.46B |
$0.20B |
2.34 |
| 2021-09-30 |
$0.44B |
$0.18B |
2.42 |
| 2021-06-30 |
$0.44B |
$0.20B |
2.23 |
| 2021-03-31 |
$0.42B |
$0.18B |
2.33 |
| 2020-12-31 |
$0.42B |
$0.19B |
2.19 |
| 2020-09-30 |
$0.40B |
$0.18B |
2.26 |
| 2020-06-30 |
$0.38B |
$0.15B |
2.51 |
| 2020-03-31 |
$0.39B |
$0.16B |
2.46 |
| 2019-12-31 |
$0.40B |
$0.19B |
2.11 |
| 2019-09-30 |
$0.40B |
$0.16B |
2.48 |
| 2019-06-30 |
$0.40B |
$0.16B |
2.55 |
| 2019-03-31 |
$0.39B |
$0.15B |
2.58 |
| 2018-12-31 |
$0.37B |
$0.16B |
2.33 |
| 2018-09-30 |
$0.36B |
$0.17B |
2.20 |
| 2018-06-30 |
$0.35B |
$0.18B |
1.97 |
| 2018-03-31 |
$0.34B |
$0.16B |
2.15 |
| 2017-12-31 |
$0.36B |
$0.15B |
2.38 |
| 2017-09-30 |
$0.36B |
$0.14B |
2.56 |
| 2017-06-30 |
$0.34B |
$0.13B |
2.62 |
| 2017-03-31 |
$0.33B |
$0.13B |
2.66 |
| 2016-12-31 |
$0.33B |
$0.11B |
2.90 |
| 2016-09-30 |
$0.37B |
$0.11B |
3.27 |
| 2016-06-30 |
$0.37B |
$0.11B |
3.49 |
| 2016-03-31 |
$0.37B |
$0.10B |
3.57 |
| 2015-12-31 |
$0.36B |
$0.12B |
3.01 |
| 2015-09-30 |
$0.38B |
$0.11B |
3.44 |
| 2015-06-30 |
$0.37B |
$0.11B |
3.41 |
| 2015-03-31 |
$0.37B |
$0.11B |
3.30 |
| 2014-12-31 |
$0.38B |
$0.12B |
3.29 |
| 2014-09-30 |
$0.39B |
$0.12B |
3.17 |
| 2014-06-30 |
$0.39B |
$0.11B |
3.68 |
| 2014-03-31 |
$0.37B |
$0.10B |
3.64 |
| 2013-12-31 |
$0.37B |
$0.11B |
3.35 |
| 2013-09-30 |
$0.36B |
$0.10B |
3.61 |
| 2013-06-30 |
$0.36B |
$0.10B |
3.62 |
| 2013-03-31 |
$0.35B |
$0.10B |
3.64 |
| 2012-12-31 |
$0.35B |
$0.13B |
2.79 |
| 2012-09-30 |
$0.35B |
$0.13B |
2.75 |
| 2012-06-30 |
$0.34B |
$0.14B |
2.50 |
| 2012-03-31 |
$0.35B |
$0.17B |
2.12 |
| 2011-12-31 |
$0.36B |
$0.13B |
2.72 |
| 2011-09-30 |
$0.37B |
$0.23B |
1.59 |
| 2011-06-30 |
$0.37B |
$0.21B |
1.75 |
| 2011-03-31 |
$0.36B |
$0.18B |
1.98 |
| 2010-12-31 |
$0.35B |
$0.18B |
1.95 |
| 2010-09-30 |
$0.37B |
$0.12B |
3.14 |
| 2010-06-30 |
$0.35B |
$0.11B |
3.27 |
| 2010-03-31 |
$0.35B |
$0.11B |
3.34 |
| 2009-12-31 |
$0.33B |
$0.08B |
4.12 |
| 2009-09-30 |
$0.32B |
$0.08B |
3.91 |
| 2009-06-30 |
$0.29B |
$0.06B |
4.58 |
| 2009-03-31 |
$0.29B |
$0.07B |
4.44 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.196B |
$1.245B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
